Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.
This study examines the role of s-nitrosylation in the growth of ovarian cancer using cell culture based and in vivo approaches. Using the nitrosylating agent, S-nitrosoglutathione (GSNO), a physiological nitric oxide molecule, we show that GSNO treatment inhibited proliferation of chemoresponsive a...
Guardado en:
Autores principales: | Shailendra Giri, Ramandeep Rattan, Mandar Deshpande, Jacie L Maguire, Zachary Johnson, Rondell P Graham, Viji Shridhar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04204642a0234a30a6fe94cde88ff8e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Sajad Dar, et al.
Publicado: (2017) -
S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue
por: Sonali Jindal, et al.
Publicado: (2020) -
Nuclear S-nitrosylation impacts tissue regeneration in zebrafish
por: Gianfranco Matrone, et al.
Publicado: (2021) -
Predicting S-nitrosylation proteins and sites by fusing multiple features
por: Wang-Ren Qiu, et al.
Publicado: (2021) -
Difficulties in generating specific antibodies for immunohistochemical detection of nitrosylated tubulins.
por: Anton Kamnev, et al.
Publicado: (2013)